| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 03/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 534 |
| 04/08/2021 | VACINA CONTRA SARS COV 2 | Vacina Covid-19 - Covishield | 0 | 0 | 0 | 0 | 0 | 605 |
| 04/08/2021 | VACINA CONTRA SARS COV 2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 820 |
| 05/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 684 |
| 05/08/2021 | VACINA CONTRA SARS COV 2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 120 |
| 07/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 684 |
| 07/08/2021 | VACINA CONTRA SARS COV 2 | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 75 |
| 07/08/2021 | VACINA CONTRA SARS COV 2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 80 |
| 07/08/2021 | VACINA CONTRA SARS COV 2 | Vacina Covid-19 - Covishield | 0 | 0 | 0 | 0 | 0 | 430 |
| 10/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 552 |
| 10/08/2021 | VACINA CONTRA SARS COV 2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 550 |
| 12/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 300 |
| 16/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 246 |
| 16/08/2021 | VACINA CONTRA SARS COV 2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 360 |
| 17/08/2021 | VACINA CONTRA SARS COV 2 | Vacina Covid-19 - Covishield | 0 | 205 | 0 | 0 | 0 | 205 |
| 17/08/2021 | VACINA CONTRA SARS COV 2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 570 |
| 19/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 276 |
| 19/08/2021 | VACINA CONTRA SARS COV2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 276 |
| 20/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 408 |
| 21/08/2021 | VACINA CONTRA SARS COV2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 390 |
| 23/08/2021 | VACINA CONTRA SARS COVID 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 372 |
| 24/08/2021 | VACINA CONTRA SARS COV 2 | Vacina Covid-19 - Covishield | 0 | 0 | 0 | 0 | 0 | 50 |
| 24/08/2021 | VACINA CONTRA SARS COV 2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 380 |
| 26/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 180 |
| 27/08/2021 | VACINA CONTRA SARS COV 2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 156 |
| 27/08/2021 | VACINA CONTRA SARS COV2 | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 740 |
| 02/09/2021 | Vacina contra sars covid | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 900 |
| 03/09/2021 | VACINA CONTRA SARS COV2 | Vacina Covid-19 - Covishield | 0 | 0 | 0 | 0 | 0 | 80 |
| 03/09/2021 | VACINA CONTRA SARS COV2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 474 |
| 06/09/2021 | FUNDAÇÃO OSVALDO CRUZ | Vacina Covid-19 - Covishield | 0 | 80 | 0 | 0 | 0 | 80 |
